Eplerenone 依普利酮
CAS 107724-20-9 MFCD07783647
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- Approved Therapeutics/Drug Candidates, Cell Biology, Cell Signaling and Neuroscience, Corticosteroid, Cytokines, Growth Factors and Hormones, Hormones, Pfizer Compounds, Steroid Hormones
产品应用
- ########
相关文献及参考
- [2]. Marvin J Meyers, et al. Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy. J Med Chem. 2010 Aug 26;53(16):5979-6002.
- Burgess, E., et al.: Expert. Opin. Pharmacother., 5, 2573 (2004),
- Delyani, J.A., et al.: Cardiovasc. Drug Rev., 19, 185 (2001),
- Dietz J.D., et al., A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity. Hypertension 51 , 742-8, (2008) 摘要
- Imanishi T., et al., Addition of eplerenone to an angiotensin-converting enzyme inhibitor effectively improves nitric oxide bioavailability. Hypertension 51 , 734-41, (2008) 摘要
- Merck 14 ,3625
- [1]. Dhillon, S., Eplerenone: a review of its use in patients with chronic systolic heart failure and mild symptoms. Drugs, 2013. 73(13): p. 1451-6
安全信息
GHS Symbol